Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
How has the fentanyl market size changed in recent years, and what is the outlook ahead?
The fentanyl market size has grown strongly in recent years. It will grow from $16.22 billion in 2024 to $17.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to pain management needs, medical procedures and surgeries, cancer pain management, opioid analgesic market growth, aging population.
The fentanyl market size is expected to see strong growth in the next few years. It will grow to $22.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rise in chronic pain cases, expanding oncology therapies, increasing surgical procedures, public health initiatives, regulatory approval for new indications. Major trends in the forecast period include technological advancements in drug formulations, technological innovations in detection, public health and harm reduction strategies, rise in pharmaceutical applications, international collaboration and information sharing.
Download Your Free Sample PDF:
What are the top economic and technological drivers pushing fentanyl market growth?
The increasing prevalence of chronic diseases is expected to propel the growth of the fentanyl market going forward. A chronic disease is a medical condition that persists over a long period, typically for three months or more, and often continues throughout a person's life. Fentanyl is used in chronic diseases primarily to manage severe, persistent pain that other medications or interventions do not effectively control. For instance, in October 2024, according to the Heart Disease Facts, published by Centers for Disease Control and Prevention (CDC), a US-based public health agency, in the United States, coronary heart disease (CHD) was responsible for 371,506 deaths in 2022, contributing to the 702,880 total heart disease deaths that accounted for roughly 1 in every 5 deaths. Therefore, the increasing prevalence of chronic diseases is driving the growth of the fentanyl market.
class=reporthtag>Fentanyl Market Driver: Rising Demand For Pain Management Driving Fentanyl Market Growth
The increasing demand for pain management is expected to propel the growth of the fentanyl market going forward. Pain management is a medical discipline that focuses on reducing pain and improving the patient's quality of life. Fentanyl is a potent opioid that can provide highly effective pain relief, especially for individuals suffering from severe or chronic pain by reducing pain levels, enhancing physical functioning, and addressing the underlying causes of pain. For instance, in May 2022, according to the Pain Relief Foundation, a UK-based charity, arthritis and musculoskeletal conditions impact over 17 million people in the UK, causing 30 million lost working days annually, while chronic pain affects up to 62% of those over 75, indicating a growing pain burden with an aging population. Therefore, the increasing demand for pain management driving the growth of the fentanyl market.
How is the fentanyl market segmented by product, application, and end-user?
The fentanyl market covered in this report is segmented –
1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)
2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations
2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems
View The Full Market Report:
What are the key trends shaping the fentanyl market in the forecast period?
Major companies operating in the fentanyl market are developing innovative products such as Opvee and getting approvals to meet larger customer bases, more sales, and increased revenue. Opvee (nalmefene) is a potent opioid receptor blocker used to treat known or suspected opioid overdose induced by natural or synthetic opioids like fentanyl. For instance, in May 2023, Indivior PLC, a US-based pharmaceutical company, received U.S. Food and Drug Administration approval for Opvee nasal spray. It functions by preventing the effects of opioids on the brain, which can help patients who have recently overdosed get their respiration and blood pressure back to normal. Opvee is delivered as a nasal spray, making it easy to administer in emergencies. It is essential to the range of medications used to combat opioid overdoses and save lives.
Which leading companies are dominating the fentanyl market landscape?
Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.
Which geographic areas are expected to offer the highest growth opportunities in thefentanyl market?
North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Can Companies Use The Fentanyl Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Fentanyl Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment